The ability of FDG-PET/MRI to detail morphology and assess malignancy makes it a “powerful tool” for the diagnostic workup of cardiac tumors, but it should be used judiciously because of its high cost and limited availability, according to a new study from Germany in the February Journal of Nuclear Medicine. {read more here}